IT201900021483A1 - Compositions comprising xyloglucan and D-mannose and their use for the treatment of genitourinary tract disorders - Google Patents

Compositions comprising xyloglucan and D-mannose and their use for the treatment of genitourinary tract disorders

Info

Publication number
IT201900021483A1
IT201900021483A1 IT102019000021483A IT201900021483A IT201900021483A1 IT 201900021483 A1 IT201900021483 A1 IT 201900021483A1 IT 102019000021483 A IT102019000021483 A IT 102019000021483A IT 201900021483 A IT201900021483 A IT 201900021483A IT 201900021483 A1 IT201900021483 A1 IT 201900021483A1
Authority
IT
Italy
Prior art keywords
xyloglucan
mannose
compositions
treatment
genitourinary tract
Prior art date
Application number
IT102019000021483A
Other languages
Italian (it)
Inventor
Andrea Costa
Elena Madaro
Tamara Mengoni
Original Assignee
S I I T S R L Servizio Int Imballaggi Termosaldanti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S I I T S R L Servizio Int Imballaggi Termosaldanti filed Critical S I I T S R L Servizio Int Imballaggi Termosaldanti
Priority to IT102019000021483A priority Critical patent/IT201900021483A1/en
Publication of IT201900021483A1 publication Critical patent/IT201900021483A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
IT102019000021483A 2019-11-18 2019-11-18 Compositions comprising xyloglucan and D-mannose and their use for the treatment of genitourinary tract disorders IT201900021483A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102019000021483A IT201900021483A1 (en) 2019-11-18 2019-11-18 Compositions comprising xyloglucan and D-mannose and their use for the treatment of genitourinary tract disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000021483A IT201900021483A1 (en) 2019-11-18 2019-11-18 Compositions comprising xyloglucan and D-mannose and their use for the treatment of genitourinary tract disorders

Publications (1)

Publication Number Publication Date
IT201900021483A1 true IT201900021483A1 (en) 2021-05-18

Family

ID=69903953

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102019000021483A IT201900021483A1 (en) 2019-11-18 2019-11-18 Compositions comprising xyloglucan and D-mannose and their use for the treatment of genitourinary tract disorders

Country Status (1)

Country Link
IT (1) IT201900021483A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090180999A1 (en) * 2008-01-11 2009-07-16 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition
WO2011147768A1 (en) * 2010-05-24 2011-12-01 Indena S.P.A. Tamarind seed polysaccharide for use in the treatment of inflammatory diseases
ITMI20102389A1 (en) * 2010-12-23 2012-06-24 Soliva Srl KIT INCLUDING A DOSE OF ATTACK AND A DOSE OF MAINTENANCE AND / OR PROPHYLAXIS
WO2014184639A1 (en) * 2013-05-14 2014-11-20 Probiotical S.P.A. Composition comprising lactic acid bacteria for use in the preventive and/or curative treatment of recurrent cystitis
US20140364390A1 (en) * 2013-06-11 2014-12-11 Novintethical Pharma, Sagl Xyloglucan-based compositions for the treatment of gastrointestinal disorders
WO2018116238A1 (en) * 2016-12-22 2018-06-28 Neilos S.r.l. Composition for use in the treatment of disorders of the urogenital apparatus

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090180999A1 (en) * 2008-01-11 2009-07-16 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition
WO2011147768A1 (en) * 2010-05-24 2011-12-01 Indena S.P.A. Tamarind seed polysaccharide for use in the treatment of inflammatory diseases
ITMI20102389A1 (en) * 2010-12-23 2012-06-24 Soliva Srl KIT INCLUDING A DOSE OF ATTACK AND A DOSE OF MAINTENANCE AND / OR PROPHYLAXIS
WO2014184639A1 (en) * 2013-05-14 2014-11-20 Probiotical S.P.A. Composition comprising lactic acid bacteria for use in the preventive and/or curative treatment of recurrent cystitis
US20140364390A1 (en) * 2013-06-11 2014-12-11 Novintethical Pharma, Sagl Xyloglucan-based compositions for the treatment of gastrointestinal disorders
WO2018116238A1 (en) * 2016-12-22 2018-06-28 Neilos S.r.l. Composition for use in the treatment of disorders of the urogenital apparatus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; 11 December 2018 (2018-12-11), ANONYMOUS: "Urinary Tract Infection Treatment", XP055712471, retrieved from www.gnpd.com Database accession no. 6194361 *
DATABASE GNPD [online] MINTEL; 9 February 2018 (2018-02-09), ANONYMOUS: "D-Mannose Sachets for Urinary Tract Infections", XP055667529, retrieved from www.gnpd.com Database accession no. 5438003 *

Similar Documents

Publication Publication Date Title
DOP2018000010A (en) PEPTIDE INHIBITORS OF THE INTERLEUCINE RECEIVER 23 AND ITS USE TO TREAT INFLAMMATORY DISEASES
EP3866781A4 (en) Novel compositions for the treatment of inflammatory diseases
EP3583113A4 (en) Use of tgf alpha for the treatment of diseases and disorders
ZA202002166B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IT201600121601A1 (en) ORAL COMPOSITION FOR THE TREATMENT OF GASTROESOFAGEO REFLUX AND LARINGO-FARINGEO REFLUX
SG11202103191QA (en) Benzimidazole derivative for use in the treatment of inflammatory disorders
CO2017000745A2 (en) Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
IL286767A (en) Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease
SG11202104053TA (en) Compositions and methods for the treatment of estrogen-dependent disorders
IL270927B (en) 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases
IL286688A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL286677A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL283469A (en) Inhalable compositions for use in the treatment of pulmonary diseases
MA55490A (en) LIPOCALIN MUTEIN FOR THE TREATMENT OF ASTHMA
IT201900021483A1 (en) Compositions comprising xyloglucan and D-mannose and their use for the treatment of genitourinary tract disorders
MA54276A (en) MONTELUKAST FOR THE TREATMENT OF EROSIVE OSTEOARTHRITIS OF THE HAND
IL292690A (en) Mrgprx2 antagonists for the treatment of inflammatory disorders
IL286685A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201702603D0 (en) Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders
MA54058A (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTERNAL ENDOMETRIOSIS AND RECTOVAGINAL ENDOMETRIOSIS
IT201700089011A1 (en) Composition for the treatment and prevention of disorders of the male sexual sphere.
IT201600122310A1 (en) Composition for use in the treatment of bowel disorders
ITUA20163037A1 (en) Formulations for use in the treatment or prevention of urological disorders
IT201700048750A1 (en) COMPOSITION FOR THE TREATMENT OF AFTE AND BUCCALE ULCERS
EP3585768A4 (en) Sulfonamide or amide compounds, compositions and methods for the prophylaxis and/or treatment of autoimmune, inflammation or infection related disorders